Inhibikase Therapeutics (IKT) Reports In-Line Q2 EPS

Go back to Inhibikase Therapeutics (IKT) Reports In-Line Q2 EPS
(NASDAQ: IKT) Delayed: 2.38 -0.01 (0.42%)
Previous Close $2.39    52 Week High
Open $2.36    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.31    EPS
Volume 192,811